Cancer News and Research

Latest Cancer News and Research

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.

8 Nov 2010

Researchers identify gene linked to melanoma metastasis

Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.

8 Nov 2010

Ambit files registration statement with SEC for public offering of common stock

Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.

8 Nov 2010

Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydney Congress

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented positive preliminary data from fully monitored study data for the entire study population of 80 subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma.

8 Nov 2010

Radiotherapy can benefit men with high risk prostate cancer: Research

Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).

8 Nov 2010

Research Roundup: Basing insurance on results, not cost; Americans skeptical of public health efforts; seniors' comprehensive care

Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.

8 Nov 2010

Resveratrol in grapes may help fight severe malaria: Study

A compound found in the skin of grapes and used to make red wine may help fight severe malaria, raising hopes of finding a new adjunctive therapy against an illness that kills an estimated 1 million people a year, according to a study presented today at The American Society of Tropical Medicine and Hygiene 59th Annual Meeting.

8 Nov 2010

Skin to blood transformation in the lab

In a new study scientists have successfully transformed human skin cells into blood without first being sent through a primordial, stem-cell-like state. The findings were published online in the journal Nature. Earlier work has shown that fibroblast cells from mouse skin, treated with the right cocktail of chemicals, can be transformed into neurons and heart muscle. This is a first with human cells.

7 Nov 2010

GE Healthcare to commence cash tender offer to acquire Clarient

GE Healthcare, a unit of General Electric Company today will commence a cash tender offer to purchase all outstanding shares of common and preferred stock of Clarient, Inc. through a wholly owned subsidiary of GE, Crane Merger Sub, Inc.

7 Nov 2010

Onconome receives $231,000 cash grant under QTDP program

Onconome, Inc. announced today that it was awarded a cash grant totaling approximately $231,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was enacted as part of the Patient Protection and Affordable Care Act of 2010.

7 Nov 2010

FDA issues approval letter to Carestream's CR system for mammography

Carestream Health has received an approval letter from the U.S. Food and Drug Administration (FDA) for its high-resolution computed radiography (CR) system for mammography.

7 Nov 2010

Scientists discover new way to create human blood from adult skin

In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin. The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anemia will be able to have blood created from a patch of their own skin to provide transfusions.

7 Nov 2010

Americans sicker but live longer than the English: Study

According to a new study in the journal Demographics, and elderly American is not quite as healthy as his English counterpart, but does live just as long, if not longer. The study found that Americans aged 55 to 64 and 70 to 80 had higher rates of chronic diseases than same-aged English people, but they died at about the same rate. Americans aged 65 and older could be sicker than their English peers but lived longer.

5 Nov 2010

Bendigo hospital debate escalates to political level

A public rally yesterday saw Bendigo Hospital staff and patients upset that cancer services will not be consolidated in the new redeveloped facility. There were severe protests against the renovations that led to a debate between the Victorian Government and Opposition. Labor and the Coalition have both promised to rebuild the hospital. Coalition committed a $630 million to a new hospital after Labor announced a new $528 million hospital in May.

5 Nov 2010

Melanoma drug breakthrough

Two latest drugs useful in melanoma are termed as the biggest breakthrough in the last five decades say cancer experts. These drugs are the first ones to be effective in advanced forms of the cancer.

5 Nov 2010

Halozyme awarded $977,917 grant under Qualifying Therapeutic Discovery Project program

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the award of four grants totaling $977,917 under the Qualifying Therapeutic Discovery Project program. The grant funding will support Halozyme's ongoing Ultrafast Insulin, PEGPH20, HTI-501, and drug delivery development programs that are directed at addressing unmet medical needs across a broad range of therapeutic areas such as diabetes, cancer and immunology.

4 Nov 2010

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results and operational highlights for the quarter ended September 30, 2010.

4 Nov 2010

Higher-quality medical care in the U.S. than in England, says study

Older Americans are less healthy than their English counterparts, but they live as long or even longer than their English peers, according to a new study by researchers from the RAND Corporation and the Institute for Fiscal Studies in London.

4 Nov 2010

NWBT receives $490,000 in two grants under QTDP program

Northwest Biotherapeutics today announced that the company has received approximately $490,000 in two grants under the Qualified Therapeutic Discovery Project Grants Program. The maximum award was received for both grants.

4 Nov 2010

Adeona receives $488,959 grants under QTDP program to support Alzheimer's, multiple sclerosis programs

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it was awarded two grants totaling $488,959 under the Qualifying Therapeutic Discovery Project (QTDP) Program to support the Company's Alzheimer's disease and multiple sclerosis programs currently in clinical testing.

4 Nov 2010

Cancer News and Research

Latest Cancer News and Research

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

Researchers identify gene linked to melanoma metastasis

Ambit files registration statement with SEC for public offering of common stock

Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydney Congress

Radiotherapy can benefit men with high risk prostate cancer: Research

Research Roundup: Basing insurance on results, not cost; Americans skeptical of public health efforts; seniors' comprehensive care

Resveratrol in grapes may help fight severe malaria: Study

Skin to blood transformation in the lab

GE Healthcare to commence cash tender offer to acquire Clarient

Onconome receives $231,000 cash grant under QTDP program

FDA issues approval letter to Carestream's CR system for mammography

Scientists discover new way to create human blood from adult skin

Americans sicker but live longer than the English: Study

Bendigo hospital debate escalates to political level

Melanoma drug breakthrough

Halozyme awarded $977,917 grant under Qualifying Therapeutic Discovery Project program

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Higher-quality medical care in the U.S. than in England, says study

NWBT receives $490,000 in two grants under QTDP program

Adeona receives $488,959 grants under QTDP program to support Alzheimer's, multiple sclerosis programs

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in